Sponsored by Pfizer. Directed to a U.S. audience.
Executive Overview
The transition into motherhood is widely acknowledged as one of the most profound physiological and psychological milestones in a person’s life. Yet, despite its universality, the profound reality of this identity shift often catches first-time parents entirely unawares. On a single day, two entities are born: the infant into the physical world, and the individual into the complex, demanding role of a mother.
Recently, on an episode of The Motherly Podcast, actress Chloe Bridges and board-certified OBGYN Dr. Charis Chambers sat down for a candid, deeply personal conversation about this transformative journey. Moving past the curated perfection often projected on social media, the two mothers discussed the messy, beautiful reality of new parenthood. They explored the necessity of building a supportive village, letting go of hyper-independence, and confronting the invisible responsibilities of pregnancy—chief among them, learning how to safeguard newborns against formidable health threats like respiratory syncytial virus (RSV).
This comprehensive report examines the multifaceted landscape of modern first-time motherhood, drawing insights from Bridges and Dr. Chambers. It explores the psychological evolution of new parents, the critical importance of trusted medical guidance during pregnancy, and the vital public health strategies surrounding infant RSV prevention.
Detailed Chronology: The Arc of Transition
The journey of motherhood does not begin in the delivery room; rather, it unfolds across a continuous timeline marked by distinct phases of anticipation, adaptation, and ongoing evolution.
The Pregnancy Phase: A Crash Course in Invisible Responsibility
For many expectant parents, pregnancy serves as an abrupt introduction to a heightened state of awareness and responsibility. As Chloe Bridges noted during her conversation, the psychological pivot occurs the moment a person realizes their choices no longer affect them in isolation.
- Behavioral and Dietary Shifts: Routine decisions—such as monitoring caffeine consumption, meticulously avoiding foods associated with listeria risks, and adhering strictly to prenatal vitamin regimens—take on a profound new weight.
- Navigating High-Risk Realities: For Dr. Charis Chambers, who experienced a high-risk pregnancy characterized by a shortened cervix, the challenge went beyond routine dietary choices. She recounted the difficult mental calculus required when medical evaluations coincided with personal milestones, such as deciding whether to attend a best friend’s bachelorette celebration in a remote location while weighing potential risks of extreme prematurity. Her experience underscores a universal truth of pregnancy: expectant mothers must frequently reconcile personal desires with uncompromising medical realities, ultimately relying on deeply rooted personal values and trusted medical teams.
The Delivery and Immediate Postpartum: The Surreal Awakening
The arrival of the newborn brings an instantaneous restructuring of reality. Describing her mindset immediately following the birth of her son, Beau, in February 2024, Bridges reflected on the surreal nature of the transition, noting that she initially "didn’t know what she didn’t know."
Dr. Chambers described a similar moment of suspension, noting that upon her son Joshua’s arrival, her preexisting mental frameworks, professional checklists, and daily blueprints instantly dissolved. This dissolution brought an immediate wave of immense joy juxtaposed against a profound, proportional nervousness regarding the caliber of responsibility she had just undertaken.
The Postpartum Evolution: Embracing Impermanence and Delegated Support
As the newborn phase gives way to late infancy, mothers face daily challenges that test their mental resilience. Both women highlighted two vital lessons learned during this period:
- The Principle of Impermanence: Bridges emphasized that early parental anxiety is often rooted in catastrophic thinking—fearing that a single difficult day of poor sleep or missed naps dictates the future. Learning that "everything is a phase" allowed her to detach from daily micro-crises.
- The Deconstruction of Hyper-Independence: Dr. Chambers, drawing on her professional background as a high-achieving physician, candidly addressed the cultural trap of treating motherhood as a test of endurance. She emphasized that suffering does not earn a badge of honor, articulating the necessity of shedding self-reliance in favor of asking for—and accepting—help from a trusted village.
Supporting Context & Metrics: Understanding RSV and Infant Vulnerability
While navigating registries, sleep schedules, and postpartum recovery occupies much of an expectant mother’s mental bandwidth, navigating invisible health risks represents one of the most critical responsibilities of pregnancy. Among these, respiratory syncytial virus (RSV) demands prioritized attention.
What is RSV and Why Does It Threaten Infants?
RSV is a highly contagious respiratory virus that circulates with notable seasonality, typically peaking during the fall and winter months across the United States. While older children and healthy adults often experience mild, cold-like symptoms, the virus poses a severe threat to infants, particularly during their first six months of life.
- Hospitalization Metrics: RSV is recognized as the leading cause of hospitalization for babies in the United States.
- Early Vulnerability: Statistical data reveals that nearly 50% of all RSV-related infant hospitalizations occur within the first three months of life, a window when neonatal immune systems are still slowly developing. Severe cases can lead to lower respiratory tract disease (LRTD), bronchiolitis, pneumonia, and, in severe instances, infant mortality.
Recognizing the Clinical Signs
Unlike standard colds or seasonal flu, which may present primarily with fevers or systemic lethargy, RSV in infants frequently manifests as distress related to the mechanics of breathing. Dr. Chambers highlights several clinical red flags:
- Increased Work of Breathing: Noticeable chest retractions (skin pulling in around the ribs or neck with each breath).
- Rapid, Noisy Respiration: Fast, labored breathing accompanied by wheezing or grunting.
- Profound Exhaustion: Extreme fatigue resulting from the physical effort required to breathe.
Because infant RSV presentations can deteriorate rapidly, medical professionals strongly advise parents to seek immediate evaluation if any respiratory symptoms emerge in a newborn.
Official Guidance & Maternal Immunization Strategies
Given that infants under six months are at the highest risk of severe outcomes, modern prenatal care increasingly emphasizes preventative strategies administered during pregnancy.
How Maternal Immunization Works
Maternal immunization leverages the natural physiological process by which pregnant individuals generate antibodies in response to specific pathogens and passively transfer them across the placenta to the developing fetus.
When an expectant mother receives an approved maternal RSV vaccine during the designated window of pregnancy, her immune system produces protective antibodies. These antibodies are transferred to the infant, offering systemic defense from the moment of birth through the first critical months of life when vulnerability is at its peak.
Clinical Considerations and Vaccination Guidelines
Public health and clinical guidelines outline specific parameters for maternal RSV immunization:
- Timing Constraints: To avoid potential risks associated with preterm birth, vaccination with ABRYSVO® (Respiratory Syncytial Virus Vaccine), manufactured by Pfizer, is indicated for pregnant individuals at 32 through 36 weeks gestational age.
- Seasonal Administration: Protection aims to cover infants during peak RSV seasons (September through January in most regions of the U.S.).
- Safety Profile: Clinical data indicates that the most common local and systemic side effects experienced by pregnant individuals include injection site pain, headaches, muscle pain (myalgia), and nausea. In infants, potential side effects or associated outcomes can include low birth weight and transient jaundice.
- Contraindications: ABRYSVO should not be administered to individuals with a documented history of severe allergic reactions, such as anaphylaxis, to any of the vaccine’s components. Furthermore, post-marketing surveillance and clinical evaluations have noted an increased risk of Guillain-Barré syndrome (a severe condition causing muscle weakness) following vaccination with ABRYSVO.
Patients are encouraged to consult their OBGYN or healthcare provider to weigh the individual risks and benefits of vaccination. Healthcare providers and patients are also urged to report any adverse events to the Vaccine Adverse Event Reporting System (VAERS) via www.vaers.hhs.gov or by calling 1-800-822-7967. Additionally, individuals who received ABRYSVO during pregnancy are encouraged to enroll in the pregnancy exposure registry by calling 1-800-616-3791 to help monitor long-term pregnancy and infant outcomes.
Future Outlook: Building the Village and Cultivating Lasting Bonds
As modern parents navigate the overwhelming noise of social media, digital group chats, unsolicited advice from family members, and medical guidance, the consensus among healthcare experts and experienced mothers alike is clear: intentionality and trust are paramount.
Filtering the Noise
Both Chloe Bridges and Dr. Charis Chambers emphasize the importance of curating a reliable support system. For Dr. Chambers, managing high-risk medical decisions required a cohesive, cross-disciplinary team of specialists—including maternal-fetal medicine physicians, nephrologists, and her delivering OBGYN—all aligned on a unified care plan. For Bridges, building trust with her OBGYN provided an essential anchor amidst the sea of conflicting online content and registry options.
Redefining Motherhood on One’s Own Terms
Looking toward the future, both women reflect on the legacy they hope to leave for their children. Bridges expresses a desire to balance competence with playfulness, ensuring that her son looks back on his childhood remembering joy and laughter alongside nurturing care. Dr. Chambers envisions a relationship built on unconditional trust, where her son knows that her parenting decisions—rooted in love and foresight before he was even born—were designed to offer him a foundation of enduring support.
Ultimately, the transition into motherhood requires acknowledging that self-sufficiency must give way to community. By building a trusted village, leaning on evidence-based medical guidance, and proactively addressing invisible health threats like RSV, expectant mothers can step into their new identities equipped not only to survive the early phases of parenthood, but to thrive within them.
Important Safety Information & Use:
ABRYSVO is a vaccine indicated for pregnant individuals at 32 through 36 weeks gestational age for the prevention of lower respiratory tract disease (LRTD) and severe LRTD caused by respiratory syncytial virus (RSV) in infants from birth through six months of age. Ask your healthcare provider about the risks and benefits of ABRYSVO to determine if it is right for you. For full prescribing information, visit pfi.sr/ABRYSVO_PI.
PP-A1G-USA-3233 ©2026 Pfizer Inc. All rights reserved. September 2026.
